Respiratory
News on diagnostics for respiratory pathogens, including influenza, coronavirus, and more.
The firm will enter clinical trials in November for a combined flu, RSV, and COVID test and expects to debut additional small syndromic panels later.
BARDA Initiatives Award Approximately $2.8M to Four Diagnostics Developers
The contracts were awarded to Karius, Signature Science, In Diagnostics, and Tufts University through BARDA's Agnostic Diagnostics and Lab at Home initiatives.
Nuclein Submits Combo COVID, Flu Point-of-Care RT-qPCR Test for FDA 510(k) Clearance, CLIA Waiver
The cartridge-based test detects SARS-CoV-2, influenza A, and influenza B in approximately 15 minutes.
BioMérieux Respiratory/Sore Throat Mini Panel Gets FDA Special 510(k) Clearance, CLIA Waiver
The firm said that it expects its SpotFire Respiratory/Sore Throat (R/ST) Panel Mini test to be available in the US in the third quarter of 2024.
Watmind Gets Two EUAs for OTC, POC COVID-19/Flu A&B Self-Tests
The tests are now available in the US and will be distributed by Biolabs International.
Apr 24, 2024
Mar 15, 2024
Aug 22, 2023
May 24, 2023
Domus Diagnostics Wins $2.4M NIH RADx Tech Contract
Feb 16, 2023
Jun 24, 2022
Almac, AstraZeneca Strike CDx Development Pact
May 11, 2022
Oct 21, 2021